Skip Ribbon Commands
Skip to main content


Drug Class: Commonly Known As: Category:
Bruton Tyrosine Kinase Inhibitor Imbruvica® Cancer-related

Ibrutinib - What is it for

Ibrutinib is a targeted medication used to treat chronic lymphocytic leukemia, Waldenström’s macroglobulinemia and mantle cell lymphoma.

Ibrutinib - Additional Information

  • Updated on 2/28/2019 12:00:00 AM
  • Article contributed by Department of Pharmacy National Cancer Centre Singapore
The information provided is not intended as medical advice. Terms of use. Information provided by SingHealth


Find Your Medicines